France’s Gemme Unveils Three-Point Plan To Bolster Biosimilars
As Biosimilar Penetration Falls Short Of Government’s ‘Ambitious’ Target
Fresh impetus is needed to help biosimilars achieve their full potential in France, according to off-patent industry association Gemme. The organization has unveiled a three-point plan to bolster the sector that includes proposals to allow pharmacists to substitute biosimilars for brand prescriptions under certain circumstances.
